NDC 69448-014

CAMCEVI

Leuprolide

CAMCEVI is a Subcutaneous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Accord Biopharma, Inc.. The primary component is Leuprolide Mesylate.

Product ID69448-014_d7a8761a-d954-413a-e053-2a95a90a60ee
NDC69448-014
Product TypeHuman Prescription Drug
Proprietary NameCAMCEVI
Generic NameLeuprolide
Dosage FormInjection, Emulsion
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2022-03-07
Marketing CategoryNDA /
Application NumberNDA211488
Labeler NameAccord BioPharma, Inc.
Substance NameLEUPROLIDE MESYLATE
Active Ingredient Strength42 mg/.37g
Pharm ClassesGonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69448-014-63

1 SYRINGE in 1 CARTON (69448-014-63) > .37 g in 1 SYRINGE
Marketing Start Date2022-03-07
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [CAMCEVI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CAMCEVI
CAMCEVI
90733116 not registered Live/Pending
Foresee Pharmaceuticals Co., Ltd.
2021-05-25
CAMCEVI
CAMCEVI
87953162 not registered Live/Pending
FORESEE PHARMACEUTICALS, Co LTD.
2018-06-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.